Search research articles
Contact Us
Filters
Showing results (1-10 of 29) with videos related to
Page
of 3
Sort By:
BMJ (Clinical Research Ed.)
|
September 15, 1990
Aetiological importance of ovulation in epithelial ovarian cancer: a population based study
D J Cruickshank
Lancet (London, England)
|
March 5, 1988
Screening for ovarian cancer by CA-125 measurement
D J Cruickshank
BMJ (Clinical Research Ed.)
|
November 16, 1991
Chemotherapy in advanced ovarian cancer
D J Cruickshank
Journal of Obstetrics and Gynaecology : the Journal of the Institute of Obstetrics and Gynaecology
|
October 30, 2004
Incrustation of the thread of an intrauterine contraceptive device
S Maiti, D J Cruickshank
International Journal of Cancer
|
January 15, 1987
Circulating tumor-associated antigen detected by the monoclonal antibody HMFG2 in human epithelial ovarian cancer
B G Ward, D J Cruickshank
BMJ (Clinical Research Ed.)
|
November 10, 1990
Atenolol in essential hypertension during pregnancy
D J Cruickshank, D M Campbell
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
February 1, 2006
Routine follow-up after treatment for a gynecological cancer: a survey of practice
F M Kew, D J Cruickshank
Journal of Obstetrics and Gynaecology : the Journal of the Institute of Obstetrics and Gynaecology
|
October 30, 2004
Plasma cell vaginitis--a new clinical entity?
M Cameron, J Morgan, D J Cruickshank
British Journal of Obstetrics and Gynaecology
|
July 1, 1987
The clinical significance of pre-operative serum CA 125 in ovarian cancer
D J Cruickshank, W T Fullerton, A Klopper
The International Journal of Biological Markers
|
October 1, 1991
The potential value of CA125 as a tumour marker in small volume, non-evaluable epithelial ovarian cancer
D J Cruickshank, P B Terry, W T Fullerton
Page
of 3
Search research articles
Search
Showing results (1-10 of 29) with videos related to
Sort By:
Page
of 3
BMJ (Clinical Research Ed.)
|
September 15, 1990
Aetiological importance of ovulation in epithelial ovarian cancer: a population based study
D J Cruickshank
Lancet (London, England)
|
March 5, 1988
Screening for ovarian cancer by CA-125 measurement
D J Cruickshank
BMJ (Clinical Research Ed.)
|
November 16, 1991
Chemotherapy in advanced ovarian cancer
D J Cruickshank
Journal of Obstetrics and Gynaecology : the Journal of the Institute of Obstetrics and Gynaecology
|
October 30, 2004
Incrustation of the thread of an intrauterine contraceptive device
S Maiti, D J Cruickshank
International Journal of Cancer
|
January 15, 1987
Circulating tumor-associated antigen detected by the monoclonal antibody HMFG2 in human epithelial ovarian cancer
B G Ward, D J Cruickshank
BMJ (Clinical Research Ed.)
|
November 10, 1990
Atenolol in essential hypertension during pregnancy
D J Cruickshank, D M Campbell
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
February 1, 2006
Routine follow-up after treatment for a gynecological cancer: a survey of practice
F M Kew, D J Cruickshank
Journal of Obstetrics and Gynaecology : the Journal of the Institute of Obstetrics and Gynaecology
|
October 30, 2004
Plasma cell vaginitis--a new clinical entity?
M Cameron, J Morgan, D J Cruickshank
British Journal of Obstetrics and Gynaecology
|
July 1, 1987
The clinical significance of pre-operative serum CA 125 in ovarian cancer
D J Cruickshank, W T Fullerton, A Klopper
The International Journal of Biological Markers
|
October 1, 1991
The potential value of CA125 as a tumour marker in small volume, non-evaluable epithelial ovarian cancer
D J Cruickshank, P B Terry, W T Fullerton
Page
of 3